jrnls.org logo
Submit

BROWSE ALL JOURNALS

SEE ALL 19 JOURNALS
Journal of Young PharmacistsNOW IN
Article

Evaluation of Anti-Gout Effect of Polyherbal Formulation Acupen in Monosodium Urate Crystal-Induced Gouty Arthritis via Anti-Inflammatory Action in Experimental Animal Model

Atul Desai1★, Hemshree Desai2, Rutvij Desai3, Anali Patel4, Chirag Desai4, Ankit Merai4, Arindam Paul4★ Corresponding author

  1. 1Ayurveda Physician, Dhanvantari Clinic, Ayurveda Health Care and Research Centre, Vyara, Gujarat, INDIA.
  2. 2Modern Medicine Practitioner, Dhanvantari Clinic, Ayurveda Health Care and Research Centre, Vyara, Gujarat, INDIA.
  3. 3Manila Central University, Caloocan, Manila, PHILIPPINES.
  4. 4Department of Pharmacology, ROFEL Shri G.M. Bilakhia College of Pharmacy, Rajju Shroff ROFEL University (RSRU), Vapi, Gujarat, INDIA.

CORRESPONDENCE

Atul Desai

Ayurveda Physician, Dhanvantari Clinic, Ayurveda Health Care and Research Centre, Vyara, Gujarat, INDIA.

dratuldesai@rediffmail.com

Received: 27-02-2025; Revised: 09-05-2025; Accepted: 18-07-2025.

Volume 17, Issue 3 · pp. 653–660 · PUBLISHED · DOI: 10.5530/jyp.20251785

View on JYP original site ↗

ABSTRACT

Aim:This study aimed to evaluate the anti-gout activity of ACUPEN formulation using the Monosodium Urate (MSU)-induced gouty arthritis model and assess its Xanthine Oxidase (XO) inhibitory activity. Materials and Methods:Wistar albino rats were divided into six groups. The control group received normal saline, while the other groups were administered 50 μL of MSU crystals (25 mg/mL) intra-articularly into the right ankle joint under anesthesia. The study analyzed the swelling ratio, inflammation index, dysfunction index, gait analysis, and serum uric acid levels. Histopathological studies of the liver, kidney, and joints were also performed. The xanthine oxidase inhibitory activity of ACUPEN tablets was measured spectrophotometrically by quantifying the conversion of xanthine to uric acid and comparing it with the activity of allopurinol. Results:Treatment groups showed a significant reduction in inflammation and swelling at 12 and 24 hr. The high-dose ACUPEN group (600 mg/kg) demonstrated a significant improvement in inflammation at 48 hr. The XO in vitrostudy revealed an IC50 value of 24.8 for ACUPEN. Gait scores in treatment groups decreased, indicating symptom alleviation. No abnormalities were observed in liver and kidney biopsies. Conclusion:ACUPEN tablets exhibited significant XO inhibitory activity in vitroand demonstrated improvements in inflammation, dysfunction, and gait. These findings suggest that ACUPEN may effectively manage gouty arthritis by reducing hyperuricemia and inflammation. Further clinical studies are needed to confirm these effects in vivoand evaluate their safety and efficacy in humans.

KEYWORDS

Open in new tab

REFERENCES

As published

Showing references and in-text citations exactly as published.

    Cite this article

    SELECT FORMAT

    Desai, A., Desai, H., Desai, R., Patel, A., Desai, C., Merai, A., & Paul, A. (). Evaluation of Anti-Gout Effect of Polyherbal Formulation Acupen in Monosodium Urate Crystal-Induced Gouty Arthritis via Anti-Inflammatory Action in Experimental Animal Model. Journal of Young Pharmacists, 17(3), 653–660. https://doi.org/10.5530/jyp.20251785